您当前的位置：
首页 >
文章列表页 >
Potential confusion risk screening and display-name optimization for Chinese drug names based on a multimodal similarity model
更新时间：2026-10-12

    • Potential confusion risk screening and display-name optimization for Chinese drug names based on a multimodal similarity model

    • ZHONGGUO YAOFANG   Vol. 37, Issue 19, Pages: 2570-2576(2026)

    • DOI：10.6039/j.issn.1001-0408.2026.19.15    

      CLC： R952

    • Received：19 May 2026，

      Revised：2026-09-20，

      Accepted：24 September 2026，

      Published：15 October 2026

    移动端阅览

  • WANG Feng,WANG Qi,FAN Yuanyuan,et al.Potential confusion risk screening and display-name optimization for Chinese drug names based on a multimodal similarity model[J].ZHONGGUO YAOFANG,2026,37(19):2570-2576. DOI： 10.6039/j.issn.1001-0408.2026.19.15.

  •  
  •  

0

Views

0

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Study on the influencing factors of venetoclax trough concentration and its association with efficacy in patients with acute myeloid leukemia
Guidelines for standardized implementation of pharmacist-managed clinics （2026 edition）
Study on the mechanism of Euphorbia hirta L.-derived exosome-like nanovesicles regulating Nrf2/HO-1/NQO1 pathway to improve acetaminophen-induced liver injury
Evidence-based expert consensus on the clinical application and pharmaceutical management of antibody-based drugs for the treatment of myasthenia gravis
Research progress on the intervention of sarcopenia with traditional Chinese medicine based on the AMPK signaling pathway

Related Author

No data

Related Institution

No data
0